MJoTAtalks

Dr Susanna's guide to

www.MJoTA.org
click here

www.MJoTAtalks.org click here

www.drsusanna.org click here



Dr Susanna loves the countries and the peoples of Africa
 
Bookmark and Share
Diabetes news from the American Diabetes Association

Latest Top (20) News
Diabetes News
Diabetes news from the National Institutes of Health Diabetes Educators.

Latest Top (10) News
Clinical trials testing therapies for diabetes

Latest Top (10) News


Dyslipidemia and Diabetic Retinopathy
Conditions:   Diabetic Retinopathy;   Dyslipidemia
Interventions:   Other: 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy;   Other: Healthy Controls 15 age matched control subjects
Sponsors:   University of Alabama at Birmingham;   National Eye Institute (NEI)
Recruiting

Thu, 18 Jan 2018 12:00:00 EST


High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes
Conditions:   Atherosclerotic Cardiovascular Disease;   Type 2 Diabetes
Interventions:   Drug: Rosuvamibe;   Drug: Monorova
Sponsor:   Yuhan Corporation
Not yet recruiting

Thu, 18 Jan 2018 12:00:00 EST


INcreasing Veteran EngagemeNT to Prevent Diabetes (INVENT)
Condition:   Prediabetes
Intervention:   Behavioral: INVENT Secure Messaging Intervention
Sponsor:   VA Office of Research and Development
Not yet recruiting

Thu, 18 Jan 2018 12:00:00 EST


Metabolomics of the Dietary Approaches to Stop Hypertension (DASH) Dietary Pattern
Conditions:   Dietary Modification;   Blood Pressure
Interventions:   Behavioral: DASH diet;   Behavioral: Fruits and vegetables diet;   Behavioral: Control diet
Sponsors:   Johns Hopkins Bloomberg School of Public Health;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed

Thu, 18 Jan 2018 12:00:00 EST


Raspberries and Postprandial Metabolism
Condition:   Type 2 Diabetes Mellitus
Intervention:   Other: Raspberries
Sponsor:   Oklahoma State University
Completed

Thu, 18 Jan 2018 12:00:00 EST


Carbohydrate Content in the Diet in Type 1 Diabetes
Condition:   Diabetes Mellitus, Type 1
Interventions:   Other: Moderate carbohydrate diet;   Other: Higher carbohydrate diet
Sponsor:   Vastra Gotaland Region
Recruiting

Wed, 17 Jan 2018 12:00:00 EST


Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES
Conditions:   Coronary Artery Disease;   Diabetes
Intervention:   Device: device implantation during coronary angioplasty
Sponsors:   Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS;   Mediolanum Cardio Research
Not yet recruiting

Wed, 17 Jan 2018 12:00:00 EST


Eliminating Hepatitis C Virus
Conditions:   Hepatitis C;   HIV;   Type2 Diabetes
Intervention:  
Sponsor:   Icahn School of Medicine at Mount Sinai
Recruiting

Wed, 17 Jan 2018 12:00:00 EST


Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin
Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: Insulin Degludec;   Drug: Insulin Glargine
Sponsor:   Yale University
Not yet recruiting

Wed, 17 Jan 2018 12:00:00 EST


Retinal Neuro-vascular Coupling in Patients With Non-arteritic Anterior Ischemic Optic Neuropathy
Condition:   Anterior Ischemic Optic Neuropathy
Interventions:   Device: Dynamic Vessel Analyzer (DVA);   Device: Fourier Domain Doppler Optical Coherence Tomography (FDOCT);   Device: Optical coherence tomography (OCT)
Sponsor:   Medical University of Vienna
Recruiting

Wed, 17 Jan 2018 12:00:00 EST
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


Statement from FDA Commissioner Scott Gottlieb, M.D., in response to GAO report regarding FDA’s ongoing commitment to employing a least burdensome approach to device review
Statement from FDA Commissioner Scott Gottlieb, M.D., in response to GAO report regarding FDA’s ongoing commitment to employing a least burdensome approach to device review

Tue, 16 Jan 2018 14:36:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D. responding to report from GAO and updating on FDA’s ongoing efforts to increase access to complex generic drugs
GAO issued the report “Generic Drugs: FDA Should Make Public Its Plans to Issue and Revise Guidance on Nonbiological Complex Drugs,” which contains a single recommendation for the FDA -- that the agency publicly announce its plans to issue or revise guidance for these drug products. The FDA agrees and is actively working to accomplish this goal.

Tue, 16 Jan 2018 14:20:00 -0500


FDA Commissioner Scott Gottlieb, M.D., updates on some ongoing shortages related to IV fluids
FDA updates on some ongoing shortages related to IV fluids

Tue, 16 Jan 2018 13:11:00 -0500


FDA and DoD launch program to expedite availability of medical products for the emergency care of American military personnel
The U.S. Food and Drug Administration and the Department of Defense launch of a joint program to prioritize the efficient development of safe and effective medical products intended to save the lives of American military personnel.

Tue, 16 Jan 2018 10:06:00 -0500


FDA Commissioner Scott Gottlieb, M.D., on new steps FDA is taking to enhance transparency of clinical trial information to support innovation and scientific inquiry related to new drugs
FDA takes steps to enhance transparency of clinical trial data used in support of new drug approvals

Tue, 16 Jan 2018 08:34:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA decision to seek additional time to reassess rule that would have changed longstanding practices for how the agency determined the ‛intended use’ of medical products
: FDA decision to seek additional time to reassess rule that would have changed longstanding practices for how the agency determined the ‛intended use’ of medical products

Fri, 12 Jan 2018 10:20:00 -0500


FDA approves first treatment for breast cancer with a certain inherited genetic mutation
FDA approves first treatment for breast cancer with a certain inherited genetic mutation

Fri, 12 Jan 2018 09:37:00 -0500


FDA warns Becton Dickinson & Company of significant violations of the law as part of ongoing investigation into lead testing issues
FDA warns Becton Dickinson & Company of significant violations of the law as part of ongoing investigation into lead testing issues

Thu, 11 Jan 2018 14:38:00 -0500


FDA acts to protect kids from serious risks of opioid ingredients contained in some prescription cough and cold products by revising labeling to limit pediatric use
The U.S. Food and Drug Administration announced today that it is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years old because the serious risks of these medicines outweigh their potential benefits in this population. After safety labeling changes are made, these products will no longer be indicated for use to treat cough in any pediatric population and will be labeled for use only in adults aged 18 years and older. Labeling for the medications also is being updated with additional safety information for adult use – including an expanded Boxed Warning, the FDA’s most prominent warning ‒ notifying about the risks of misuse, abuse, addiction, overdose and death, and slowed or difficult breathing that can result from exposure to codeine or hydrocodone.

Thu, 11 Jan 2018 12:18:00 -0500


Statement by FDA Commissioner Scott Gottlieb, M.D., update on recovery efforts in Puerto Rico, and continued efforts to mitigate IV saline and amino acid drug shortages
Statement by FDA Commissioner Scott Gottlieb, M.D., update on recovery efforts in Puerto Rico, and continued efforts to mitigate IV saline and amino acid drug shortages

Thu, 04 Jan 2018 14:30:00 -0500